efficacy of transcranial ultrasound in the treatment of patients with mild cognitive
impairment or dementia.
– CDR stage of at least 0.5 (mild cognitive impairment)
– At least one pathognomic imaging biomarker of a neurodegenerative process.
– Cognitive decline clearly related to an acute illness
– Subjects unable to give informed consent
– Subjects with scalp rash or open wounds on the scalp (for example from treatment of
squamous cell cancer)
– Advanced terminal illness
– Advanced kidney, pulmonary, cardiac or liver failure
– Subjects who would not be able to lay down without excessive movement in a calm
environment sufficiently long enough to be able to achieve sleep
– Subjects with major depressive disorder
– Subjects with vascular causes of dementia
- Neurological Associates of West LA, Santa Monica, California, United States, 90403